4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-22-036176
EVP, Chief Financial Officer sold 653 shares at $17.91 ($11,695)
- EVP, Chief Financial Officer acquired 1,893 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, Chief Financial Officer | 2022-06-08 | Option exercise | +1,893 | 3,995 | D | ||
| Schneyer Mark C. EVP, Chief Financial Officer | 2022-06-09 | Sale | −653 | $17.91 | $11,695 | 3,342 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, Chief Financial Officer | 2022-06-08 | Option exercise · Restricted Stock Units | −1,893 | 3,786 | D | ||
| Open-market sales · 653 sh · avg $17.91 · $11,695 | |||||||
Loading xslF345X03/doc4.xml…